RELEASE: Senators Mullin and Booker Reintroduce the Prescription Information Modernization Act

Washington, D.C. – Today, U.S. Senators Markwayne Mullin (R-OK) and Cory Booker (D-NJ) reintroduced the “Prescription Information Modernization Act of 2025”. This bill will enable the Food and Drug Administration (FDA) to implement a rule that allows drug manufacturers to share prescribing information electronically in order to reduce waste, improve efficiency, and ensure that healthcare professionals have access to the latest drug information.

Prescribing information is crucial for healthcare professionals to make informed decisions about prescriptions. Unfortunately, under current regulations, this information is required to be printed which leads to excessive paper use and the distribution of outdated materials.

“This common-sense legislation is long overdue and will have an immense impact on both our healthcare professionals and patients,” said Senator Mullin. “Electronic prescriptions will simplify how providers access and manage data, improving efficiency without compromising quality.”

“Our health care system should adapt to the latest technological advances so that people can receive efficient, quick, and effective care like never before,” said Senator Booker. “Right now, drug manufacturers and health care providers are still forced to rely on printed materials to access and manage prescription materials. This bipartisan legislation will pave the way for electronic prescriptions and modernize our health care practices.”

The legislation is supported by the following organizations: The Alliance to Modernize Prescribing Information, Academy of Managed Care Pharmacy (AMCP), Allergy & Asthma Network, American Pharmacists Association, AmGen, Asthma and Allergy Foundation of America, Association for Accessible Medicines, Beyond Type 1, Biotechnology Innovation Organization, BioNJ, BioUtah, Boomer Esiason Foundation, Environmental Paper Network, Georgia Bio, Healthcare Distribution Alliance, HealthCare Institute of New Jersey, LUNGevity Foundation, Lupin, Maryland Tech Council, MassBio, McKesson, National Association of Chain Drug Stores, National Consumers League, National Grange, NewYorkBIO, North Carolina Biosciences Organization, Texas Healthcare and Biosciences Institute, and Zero Cancer.

Full text of the ‘‘Prescription Information Modernization Act of 2025’’ can be found here.

###

Print
Share
Like
Tweet